Clinical Trials Directory

Trials / Completed

CompletedNCT02875873

Balanced Solution Versus Saline in Intensive Care Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
11,075 (actual)
Sponsor
Hospital do Coracao · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A 2x2 factorial randomized study to evaluate the effect of a balanced crystalloid solution compared with 0.9% saline, and of rapid vs. slow infusion on clinical outcomes of critically ill patients

Detailed description

Pragmatic, multicenter, 2x2 factorial randomized study. Severe patients admitted to the ICU at moderate to high risk for death or acute kidney injury will be randomly allocated to receive a balanced crystalloid solution (Plasma-Lyte®) or 0.9% saline and to receive crystalloids by rapid bolus infusion (999 mL/h) or slow infusion (333 mL/h) whenever plasma expansion is needed.

Conditions

Interventions

TypeNameDescription
DRUGPlasma-LytePlasma-Lyte will be used for fluid expansion and maintenance
DRUGSaline 0.9%Saline 0.9% will be used for fluid expansion and maintenance
OTHERSlow infusion speedWhenever fluid expansion is deemed necessary by the attending physician, infusion speed will be set at 333 mL/h. NOTE: This intervention will not be blinded.
OTHERFast Infusion SpeedWhenever fluid expansion is deemed necessary by the attending physician, infusion speed will be set at 999 mL/h. NOTE: This intervention will not be blinded.

Timeline

Start date
2017-05-27
Primary completion
2020-03-02
Completion
2021-02-28
First posted
2016-08-23
Last updated
2021-04-19

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02875873. Inclusion in this directory is not an endorsement.